Taken together, these concordant findings in multiple mouse models of T-ALL demonstrate that tumor-associated myeloid cells promote T-ALL survival and growth via activation of integrin signaling and downstream FAK/PYK2 kinases. The gene discussed is PTK2B; the disease is acute lymphoblastic leukemia.